What is GUTS (GUTS) stock price today?

GUTS (GUTS) is currently trading at $0.80, up 3.62% today.

What is GUTS P/E ratio?

GUTS's P/E ratio is -0.40. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is GUTS return on equity (ROE)?

GUTS's return on equity (ROE) is -1566.67%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is GUTS's market cap?

GUTS has a market capitalization of $57.83M.

NGM · Biotechnology

GUTS (GUTS) Stock

$0.80 +3.62% NGM: GUTS Healthcare

Valuation

Metric	Value
Price	$0.80
Market Cap	$57.83M
P/E Ratio	-0.40
P/B Ratio	4.69
P/S Ratio	0.00
EPS (TTM)	$-1.86
52-Week High	$2.44
52-Week Low	$0.38
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-1566.67%
ROA	-116.53%
ROCE	-1077.78%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	2.84
Current Ratio	4.89

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-37.0M	$-49.0M	$-51.0M	$-94.0M	$-97.0M
Net Profit	$-39.0M	$-46.0M	$-77.0M	$-69.0M	$-141.0M
EPS	$-1.12	$-1.34	$-1.98	$-1.62	$-1.86
Op Margin	—	—	-42363.3%	-100571.0%	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$103.0M	$61.0M	$76.0M	$108.0M	$121.0M
Total Liabilities	$312.0M	$313.0M	$401.0M	$80.0M	$112.0M
Cash	$95.0M	$49.0M	$34.0M	$67.0M	$82.0M
Borrowings	$304.0M	$307.0M	$374.0M	$63.0M	$62.0M

Latest News

Fractyl Health Says Revita Helped Patients Keep Weight Off After Stopping GLP-1s MarketBeat · Jul 15, 2026 Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation GlobeNewswire · Jul 15, 2026 Fractyl Health (GUTS) Stock Sees Fair Value Cut As Analysts Weigh Revita Opportunity Simply Wall St. · Jul 11, 2026 Craig-Hallum Initiates Fractyl Health at Buy With $4 Price Target MT Newswires · Jul 1, 2026 Fractyl Health Inc (GUTS) Cleared for RJVA-001 Trial. Let’s Look At Funding Insider Monkey · Jun 12, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-33.0M	$-46.0M	$-43.0M	$-66.0M	$-90.0M
Investing Cash Flow	$0	$0	$-1.0M	$-4.0M	$-1.0M
Financing Cash Flow	$0	$0	$-1.0M	$-2.0M	$0
Net Cash Flow	$66.0M	$-46.0M	$-16.0M	$34.0M	$14.0M
Free Cash Flow	$-34.0M	$-46.0M	$-43.0M	$-67.0M	$-91.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-150.88%
Quick Ratio	4.28
Interest Coverage	—
Return 1Y	-35.15%
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held1.35%

Institutions Held52.42%

Institutions Float Held53.14%

Institutional Holder	Shares	Report Date
Nantahala Capital Management, LLC	13,364,519	2026-03-31
683 Capital Management LLC	6,727,235	2026-03-31
Pale Fire Capital SE	5,921,045	2026-03-31
Vanguard Capital Management LLC	5,533,006	2026-03-31
Catalio Capital Management, LP	5,491,866	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ADVMAdverum Biotechnologies, Inc.	$4.36	+0.00%	-0.66	$96.26M	0.00%
ALXO	$1.95	-2.26%	-1.04	$261.72M	0.00%
ARTV	$11.27	-2.68%	-2.29	$278.56M	0.00%
ATYR	$0.49	+1.19%	-0.72	$47.62M	0.00%
BMEA	$1.22	+0.00%	-1.20	$88.21M	0.00%

About GUTS

GUTS is led by CEO Harith Rajagopalan, employs 107 people, headquartered in US, publicly traded since 2024.

GUTS stock trades at $0.80 with a market capitalization of $57.83M. The stock is valued at a price-to-earnings (P/E) ratio of -0.40, price-to-book of 4.69, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.38 and $2.44, and currently trades 67.3% below its 52-week high.

On profitability, GUTS generates a return on equity (ROE) of -1566.67%, return on capital employed of -1077.78%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides